Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9457038
APP PUB NO 20140256662A1
SERIAL NO

14284524

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Administration of at least one compound of the family of the avermectins or of the family of the milbemycins, notably ivermectin, is useful for the treatment of ophthalmic pathologies, including ocular rosacea.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GALDERMA HOLDING SA6300 ZUG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bouissou, Philippe Rouquefort les Pins, FR 4 57
Kaoukhov, Alexandre Juan les Pins, FR 45 128
Villard, Christophe Le Tignet, FR 7 80

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 4, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00